Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention.

Jamieson L, Garvey G, Hedges J, Mitchell A, Dunbar T, Leane C, Hill I, Warren K, Brown A, Ju X, Roder D, Logan R, Johnson N, Smith M, Antonsson A, Canfell K.

JMIR Res Protoc. 2018 Jun 8;7(6):e10503. doi: 10.2196/10503.

2.

Vascular endothelial growth factor (VEGF), transforming growth factor beta (TGFβ), angiostatin, and endostatin are increased in radiotherapy-induced gastrointestinal toxicity.

Stansborough RL, Bateman EH, Al-Dasooqi N, Bowen JM, Wignall A, Keefe DM, Yeoh AS, Logan RM, Yeoh EEK, Stringer AM, Gibson RJ.

Int J Radiat Biol. 2018 Jul;94(7):645-655. doi: 10.1080/09553002.2018.1483588.

PMID:
29855218
3.

Developmental origins of pregnancy-induced cardiac changes: establishment of a novel model using the atrial natriuretic peptide gene-disrupted mice.

Ventura NM, Li TY, Tse MY, Richard L, Tayade C, Jin AY, Andrew RD, Pang SC.

Mol Cell Biochem. 2018 May 25. doi: 10.1007/s11010-018-3359-z. [Epub ahead of print]

PMID:
29802597
4.

Matrix metalloproteinase expression is altered in the small and large intestine following fractionated radiation in vivo.

Stansborough RL, Al-Dasooqi N, Bateman EH, Bowen JM, Keefe DMK, Logan RM, Yeoh ASJ, Yeoh EEK, Stringer AM, Gibson RJ.

Support Care Cancer. 2018 May 12. doi: 10.1007/s00520-018-4255-5. [Epub ahead of print]

PMID:
29754212
5.

The effect of a single injection of irinotecan on the development of enamel in the Wistar rats.

Al-Ansari S, Jalali R, Bronckers T, Raber-Durlacher J, Logan R, de Lange J, Rozema F.

J Cell Mol Med. 2018 Mar;22(3):1501-1506. doi: 10.1111/jcmm.13415. Epub 2017 Dec 28.

6.

The Prevalence and Investigation of Risk Factors of Oral Mucositis in a Pediatric Oncology Inpatient Population; a Prospective Study.

Allen G, Logan R, Revesz T, Keefe D, Gue S.

J Pediatr Hematol Oncol. 2018 Jan;40(1):15-21. doi: 10.1097/MPH.0000000000000970.

PMID:
29045267
7.

Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.

Smith SG, Wardle J, Atkin W, Raine R, McGregor LM, Vart G, Morris S, Duffy SW, Moss S, Hackshaw A, Halloran S, Kralj-Hans I, Howe R, Snowball J, Handley G, Logan RF, Rainbow S, Smith S, Thomas M, Counsell N, von Wagner C.

BMC Cancer. 2017 Aug 14;17(1):543. doi: 10.1186/s12885-017-3512-1.

8.

Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials.

Odutayo A, Desborough MJ, Trivella M, Stanley AJ, Dorée C, Collins GS, Hopewell S, Brunskill SJ, Kahan BC, Logan RF, Barkun AN, Murphy MF, Jairath V.

Lancet Gastroenterol Hepatol. 2017 May;2(5):354-360. doi: 10.1016/S2468-1253(17)30054-7. Epub 2017 Mar 23.

PMID:
28397699
9.

Testing innovative strategies to reduce the social gradient in the uptake of bowel cancer screening: a programme of four qualitatively enhanced randomised controlled trials.

Raine R, Atkin W, von Wagner C, Duffy S, Kralj-Hans I, Hackshaw A, Counsell N, Moss S, McGregor L, Palmer C, Smith SG, Thomas M, Howe R, Vart G, Band R, Halloran SP, Snowball J, Stubbs N, Handley G, Logan R, Rainbow S, Obichere A, Smith S, Morris S, Solmi F, Wardle J.

Southampton (UK): NIHR Journals Library; 2017 Mar.

10.

Fractionated abdominal irradiation induces intestinal microvascular changes in an in vivo model of radiotherapy-induced gut toxicity.

Stansborough RL, Bateman EH, Al-Dasooqi N, Bowen JM, Keefe DMK, Yeoh ASJ, Logan RM, Yeoh EEK, Stringer AM, Gibson RJ.

Support Care Cancer. 2017 Jun;25(6):1973-1983. doi: 10.1007/s00520-017-3601-3. Epub 2017 Feb 7.

PMID:
28175996
11.

A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening.

Raine R, Moss SM, von Wagner C, Atkin W, Hans IK, Howe R, Solmi F, Morris S, Counsell N, Hackshaw A, Halloran S, Handley G, Logan RF, Rainbow S, Smith S, Snowball J, Seaman H, Thomas M, Smith SG, McGregor LM, Vart G, Wardle J, Duffy SW.

Br J Cancer. 2016 Dec 6;115(12):1479-1486. doi: 10.1038/bjc.2016.365. Epub 2016 Nov 22.

12.

A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.

Elad S, Ranna V, Ariyawardana A, Correa ME, Tilly V, Nair RG, Rouleau T, Logan RM, Pinto A, Charette V, Saunders DP, Jensen SB; Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO).

Support Care Cancer. 2017 Feb;25(2):687-700. doi: 10.1007/s00520-016-3477-7. Epub 2016 Nov 16. Review.

PMID:
27853930
13.

TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced Diarrhea.

Wardill HR, Bowen JM, Van Sebille YZ, Secombe KR, Coller JK, Ball IA, Logan RM, Gibson RJ.

Mol Cancer Ther. 2016 Nov;15(11):2767-2779. Epub 2016 Aug 22.

14.

Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction.

Wardill HR, Mander KA, Van Sebille YZ, Gibson RJ, Logan RM, Bowen JM, Sonis ST.

Int J Cancer. 2016 Dec 15;139(12):2635-2645. doi: 10.1002/ijc.30252. Epub 2016 Jul 15. Review.

15.

Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms.

Wardill HR, Gibson RJ, Van Sebille YZ, Secombe KR, Coller JK, White IA, Manavis J, Hutchinson MR, Staikopoulos V, Logan RM, Bowen JM.

Mol Cancer Ther. 2016 Jun;15(6):1376-86. doi: 10.1158/1535-7163.MCT-15-0990. Epub 2016 Mar 29.

16.

Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial.

McGregor LM, von Wagner C, Atkin W, Kralj-Hans I, Halloran SP, Handley G, Logan RF, Rainbow S, Smith S, Snowball J, Thomas MC, Smith SG, Vart G, Howe R, Counsell N, Hackshaw A, Morris S, Duffy SW, Raine R, Wardle J.

Gastroenterol Res Pract. 2016;2016:3670150. doi: 10.1155/2016/3670150. Epub 2016 Mar 16.

17.

GPCR-styrene maleic acid lipid particles (GPCR-SMALPs): their nature and potential.

Wheatley M, Charlton J, Jamshad M, Routledge SJ, Bailey S, La-Borde PJ, Azam MT, Logan RT, Bill RM, Dafforn TR, Poyner DR.

Biochem Soc Trans. 2016 Apr 15;44(2):619-23. doi: 10.1042/BST20150284. Review.

PMID:
27068979
18.

A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic options.

Wardill HR, Gibson RJ, Van Sebille YZ, Secombe KR, Logan RM, Bowen JM.

Exp Biol Med (Maywood). 2016 Jul;241(13):1386-94. doi: 10.1177/1535370216640932. Epub 2016 Mar 31.

19.

Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.

Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Sharpe MB, Laughlin S, Bartels U, Scantlebury N, Law N, Malkin D, Skocic J, Richard L, Mabbott DJ.

J Neurosurg Pediatr. 2016 Jul;18(1):29-40. doi: 10.3171/2016.1.PEDS15580. Epub 2016 Mar 25.

PMID:
27015518
20.

The development of an evidenced-based and clinically trialled Oral Health Protocol for Paediatric Oncology Patients at the Women's and Children's Hospital, Adelaide, South Australia.

Allen G, Revesz T, Logan R, Keefe D, Gue S.

Support Care Cancer. 2016 May;24(5):1933-1934. doi: 10.1007/s00520-016-3114-5. Epub 2016 Feb 19. No abstract available.

PMID:
26891842
21.

Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.

Raine R, Duffy SW, Wardle J, Solmi F, Morris S, Howe R, Kralj-Hans I, Snowball J, Counsell N, Moss S, Hackshaw A, von Wagner C, Vart G, McGregor LM, Smith SG, Halloran S, Handley G, Logan RF, Rainbow S, Smith S, Thomas MC, Atkin W.

Br J Cancer. 2016 Feb 2;114(3):321-6. doi: 10.1038/bjc.2015.413. Epub 2016 Jan 7.

22.

Development and psychometric validation of social cognitive theory scales in an oral health context.

Jones K, Parker EJ, Steffens MA, Logan RM, Brennan D, Jamieson LM.

Aust N Z J Public Health. 2016 Apr;40(2):193-5. doi: 10.1111/1753-6405.12500. Epub 2015 Dec 29.

PMID:
26714281
23.

Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.

Wardle J, von Wagner C, Kralj-Hans I, Halloran SP, Smith SG, McGregor LM, Vart G, Howe R, Snowball J, Handley G, Logan RF, Rainbow S, Smith S, Thomas MC, Counsell N, Morris S, Duffy SW, Hackshaw A, Moss S, Atkin W, Raine R.

Lancet. 2016 Feb 20;387(10020):751-9. doi: 10.1016/S0140-6736(15)01154-X. Epub 2015 Dec 9.

24.

Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer.

Wardill HR, Logan RM, Bowen JM, Van Sebille YZ, Gibson RJ.

Support Care Cancer. 2016 Apr;24(4):1779-88. doi: 10.1007/s00520-015-2964-6. Epub 2015 Oct 6.

PMID:
26441079
25.

NICE referral guidelines for suspected cancer: colorectal cancer and faecal occult blood testing.

Benton S, Steele R, Logan R, Djedovic N, Smith S, Addison C.

Ann Clin Biochem. 2016 Jan;53(Pt 1):7-9. doi: 10.1177/0004563215612507. Epub 2015 Oct 5. No abstract available.

PMID:
26438519
26.

A screening model for oral cancer using risk scores: development and validation.

Krishna Rao S, Mejia GC, Logan RM, Kulkarni M, Kamath V, Fernandes DJ, Ray S, Roberts-Thomson K.

Community Dent Oral Epidemiol. 2016 Feb;44(1):76-84. doi: 10.1111/cdoe.12192. Epub 2015 Aug 26.

PMID:
26308953
27.

Estimating the effect of childhood socioeconomic disadvantage on oral cancer in India using marginal structural models.

Krishna Rao S, Mejia GC, Roberts-Thomson K, Logan RM, Kamath V, Kulkarni M, Mittinty MN.

Epidemiology. 2015 Jul;26(4):509-17. doi: 10.1097/EDE.0000000000000312.

PMID:
25989249
28.

Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.

Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Le Jeune I, Darwent M, Church N, Reckless I, Hodge R, Dyer C, Meredith S, Llewelyn C, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF.

Lancet. 2015 Jul 11;386(9989):137-44. doi: 10.1016/S0140-6736(14)61999-1. Epub 2015 May 5.

PMID:
25956718
29.

Comment on impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.

Logan RF, Halloran SP.

Gut. 2015 Jun;64(6):1006-7. doi: 10.1136/gutjnl-2014-308902. Epub 2014 Dec 15. No abstract available.

PMID:
25512640
30.

Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity.

Wardill HR, Van Sebille YZ, Mander KA, Gibson RJ, Logan RM, Bowen JM, Sonis ST.

Cancer Treat Rev. 2015 Feb;41(2):122-8. doi: 10.1016/j.ctrv.2014.11.005. Epub 2014 Dec 5. Review.

PMID:
25512119
31.

Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study.

Coller JK, White IA, Logan RM, Tuke J, Richards AM, Mead KR, Karapetis CS, Bowen JM.

Support Care Cancer. 2015 May;23(5):1233-6. doi: 10.1007/s00520-014-2481-z. Epub 2014 Oct 16.

PMID:
25318697
32.

Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis.

Al-Azri AR, Gibson RJ, Bowen JM, Stringer AM, Keefe DM, Logan RM.

J Oral Pathol Med. 2015 Jul;44(6):459-67. doi: 10.1111/jop.12255. Epub 2014 Sep 12.

PMID:
25213123
33.

Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT).

Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, Quinn B, Epstein JB, Blijlevens NM, Waltimo T, Passweg JR, Correa ME, Dahllöf G, Garming-Legert KU, Logan RM, Potting CM, Shapira MY, Soga Y, Stringer J, Stokman MA, Vokurka S, Wallhult E, Yarom N, Jensen SB.

Support Care Cancer. 2015 Jan;23(1):223-36. doi: 10.1007/s00520-014-2378-x. Epub 2014 Sep 5. Review.

34.

The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis.

Smith T, Elwood P, Keating C, Rothwell P, Detering E, Freedman A, Langley R, Logan R, Phillips C, DeCensi A.

Ecancermedicalscience. 2014 Jan 24;8:388. doi: 10.3332/ecancer.2014.388. eCollection 2014.

35.

Influence of periodontitis on the experience of oral mucositis in cancer patients undergoing head and neck radiotherapy: a pilot study.

Khaw A, Liberali S, Logan R, Keefe D, Bartold PM.

Support Care Cancer. 2014 Aug;22(8):2119-25. doi: 10.1007/s00520-014-2186-3. Epub 2014 Mar 20.

PMID:
24647487
36.

The role of oral flora in the development of chemotherapy-induced oral mucositis.

Stringer AM, Logan RM.

J Oral Pathol Med. 2015 Feb;44(2):81-7. doi: 10.1111/jop.12152. Epub 2014 Feb 4. Review.

PMID:
24494824
37.

Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a nationwide audit.

Jairath V, Rehal S, Logan R, Kahan B, Hearnshaw S, Stanworth S, Travis S, Murphy M, Palmer K, Burroughs A.

Dig Liver Dis. 2014 May;46(5):419-26. doi: 10.1016/j.dld.2013.12.010. Epub 2014 Jan 14.

PMID:
24433997
38.

TLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity?

Wardill HR, Gibson RJ, Logan RM, Bowen JM.

Int J Cancer. 2014 Dec 1;135(11):2483-92. doi: 10.1002/ijc.28656. Epub 2014 Jan 10. Review.

39.

Mammalian target of rapamycin inhibitor-associated stomatitis.

Boers-Doets CB, Raber-Durlacher JE, Treister NS, Epstein JB, Arends AB, Wiersma DR, Lalla RV, Logan RM, van Erp NP, Gelderblom H.

Future Oncol. 2013 Dec;9(12):1883-92. doi: 10.2217/fon.13.141. Review.

40.

Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012).

Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R.

Asian Pac J Cancer Prev. 2013;14(10):5567-77. Review.

42.

Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.

Abdullah SN, Farmer EA, Spargo L, Logan R, Gully N.

Anaerobe. 2013 Oct;23:102-8. doi: 10.1016/j.anaerobe.2013.07.001. Epub 2013 Jul 13.

PMID:
23856045
43.

Emerging evidence on the pathobiology of mucositis.

Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3233-41. doi: 10.1007/s00520-013-1900-x. Epub 2013 Jul 11. Review.

PMID:
23842598
44.

Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial.

Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, Dyer C, Stokes EA, Llewelyn C, Bailey AA, Dallal H, Everett SM, James MW, Stanley AJ, Church N, Darwent M, Greenaway J, Le Jeune I, Reckless I, Campbell HE, Meredith S, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF.

Transfus Med Rev. 2013 Jul;27(3):146-53. doi: 10.1016/j.tmrv.2013.04.001. Epub 2013 May 22.

45.

Emerging evidence on the pathobiology of mucositis.

Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Jul;21(7):2075-83. doi: 10.1007/s00520-013-1810-y. Epub 2013 Apr 21. Review.

PMID:
23604521
46.

Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases.

Stringer AM, Al-Dasooqi N, Bowen JM, Tan TH, Radzuan M, Logan RM, Mayo B, Keefe DM, Gibson RJ.

Support Care Cancer. 2013 Jul;21(7):1843-52. doi: 10.1007/s00520-013-1741-7. Epub 2013 Feb 10.

PMID:
23397098
47.

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals.

Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, Armitage J, Manson JE, Hankey GJ, Spence JD, Galan P, Bønaa KH, Jamison R, Gaziano JM, Guarino P, Baron JA, Logan RF, Giovannucci EL, den Heijer M, Ueland PM, Bennett D, Collins R, Peto R; B-Vitamin Treatment Trialists' Collaboration.

Lancet. 2013 Mar 23;381(9871):1029-36.

48.

ACP Journal Club. A single FIT (≥ 50 ng Hb/mL) detected 38% of screen-detected advanced colorectal neoplasia.

Logan RF.

Ann Intern Med. 2012 Nov 20;157(10):JC5-10. doi: 10.7326/0003-4819-157-10-201211200-02010. No abstract available.

PMID:
23165686
49.

Implementation of a hospital oral care protocol and recording of oral mucositis in children receiving cancer treatment : a retrospective and a prospective study.

Qutob AF, Allen G, Gue S, Revesz T, Logan RM, Keefe D.

Support Care Cancer. 2013 Apr;21(4):1113-20. doi: 10.1007/s00520-012-1633-2. Epub 2012 Oct 26.

PMID:
23100166
50.

Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.

Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, Bowen J, Al-Azri AR, Everaus H, Gerber E, Gomez JG, Pettersson BG, Soga Y, Spijkervet FK, Tissing WJ, Epstein JB, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Jan;21(1):343-55. doi: 10.1007/s00520-012-1594-5. Epub 2012 Sep 18. Review.

PMID:
22987094

Supplemental Content

Loading ...
Support Center